Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Administration of Repurposed Ketoconazole in Glioma Patients: Early Phase 1 Clinical Trial

NCT07585851 is registered in ClinicalTrials.gov with Universitas Padjadjaran as lead sponsor.

NCT NCT07585851
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07585851 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Administration of Repurposed Ketoconazole in Glioma Patients: Early Phase 1 Clinical Trial
Lead sponsor
Universitas Padjadjaran
Phase
Phase 1
Overall status
Active, not recruiting
Start date
February 28, 2023
Completion date
August 31, 2026
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diffuse glioma, diffuse glioma, grade i, diffuse glioma, grade ii, diffuse glioma, grade iii, diffuse glioma, grade iv